OliX Pharmaceuticals, Inc (KOSDAQ:226950)
139,800
+2,100 (1.53%)
Jan 19, 2026, 3:30 PM KST
884.51% (1Y)
| Market Cap | 2.82T |
| Revenue (ttm) | 10.18B |
| Net Income (ttm) | -43.30B |
| Shares Out | 20.19M |
| EPS (ttm) | -2,280.15 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 318,802 |
| Average Volume | 553,137 |
| Open | 135,600 |
| Previous Close | 137,700 |
| Day's Range | 134,000 - 143,200 |
| 52-Week Range | 13,380 - 161,000 |
| Beta | 0.61 |
| RSI | 51.14 |
| Earnings Date | Mar 19, 2026 |